The Doris Duke Charitable Foundation (DDCF) announces the 2011 Innovations in Clinical Research Award (ICRA)

ICRA provides funding for early-stage research projects in clinical investigation as part of the Medical Research Program’s strategy to foster innovations in clinical research that advance the prevention, diagnosis, and treatment of human disease.   The 2011 ICRA competition invites proposals for cutting edge, clinical research that has the potential to accelerate innovative breakthroughs in sickle cell disease. 

The Doris Duke Charitable Foundation (DDCF) encourages application to the current ICRA competition by investigators who:

• Work in other research areas, in an effort to bring new thinking to the field of sickle cell disease research.
• Are women and under-represented minorities in medicine, including Blacks or African Americans, Hispanics or Latinos, American Indians, Alaskan Natives and Native Hawaiians.
• Will propose the following types of sickle cell disease research: 
  • Drug discovery
  • Genetic and genomic approaches to study variability in the severity of sickle cell disease, including those focused on sickle cell disease patient populations in Africa
  • Early phase corrective approaches, such as gene therapy and transplantation of blood-forming cells
  • Identification of new risk factors or predictors of outcome
  • Genetic and genomic approaches to study variability in the severity of sickle cell disease, including those focused on sickle cell disease patient populations in Africa

Areas not funded

Experiments that use animals or primary tissues derived from animals will not be supported by DDCF Medical Research Program grants.

The Letter of Intent for the 2011 Innovations in Clinical Research Award competition are due June 8, 2011.   A letter of intent is required in order to submit an application for this award.  Read more…